{"date": "2021-12-06 14:41:13.335000+00:00", "ticker": "AMZN", "mrkt_info": {"open": 3427.37, "close": 3523.16}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-body\">\n<pre>ELSE NUTRITION HOLDINGS INC (\"BABY-V\")\n- Establishes North American Office in Columbus, Ohio, Behind\n- Growth Plans\n\n     ELSE NUTRITION HOLDINGS INC. (\"Else\" or the \"Company\") the Plant-Based\nbaby, toddler and children nutrition company, announces the establishment\nof a dedicated U.S. office and operations. Consistent strong growth of Else\nNutrition product sales has led to the need for a full-time team on the\nground in the U.S.\n\n     In July of this year, Former Abbott Executive, Mike Glick joined Else\nNutrition as General Manager and VP, North America.  In his role within\nElse, Mike will oversee the rapidly growing Else Nutrition business across\nthe US and Canada. A team is being actively built out, and Mike has\nselected Westerville, Ohio (near Columbus) as the Headquarters location for\nNorth American operations.\n\n     \"The Columbus area is a vibrant, diverse metropolitan area that is\nideally located within 500 miles of two-thirds of the US population and is\nknown for talent and expertise in the nutrition industry,\" stated Mr.\nGlick. \"Due to lower-than-average housing costs, great school systems, and\ntemperate weather, it has seen tremendous growth and will continue to do so\nas we expand as a company. This is a great place to work, and we're excited\nto build out the local team.\"\n\n     Else North America office is located at 501 W. Schrock Road,\nWesterville, Ohio with a team of 5 currently. Offering new team members a\ncompetitive remuneration package, the Company expects to double this in the\ncoming year to keep up with the expected growth.\n\n     About Else Nutrition Holdings Inc.\n\n     Else Nutrition GH Ltd. is an Israel-based food and nutrition company\nfocused on developing innovative, clean and plant-based food and nutrition\nproducts for infants, toddlers, children, and adults. Its revolutionary,\nplant-based, non-soy, formula is a clean-ingredient alternative to\ndairy-based formula. Else Nutrition (formerly INDI) won the \"2017 Best\nHealth and Diet Solutions\" award at the Global Food Innovation Summit in\nMilan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked\nas the #1 Top seller in the baby and toddler formula category on Amazon.\nThe holding company, Else Nutrition Holdings Inc., is a publicly traded\ncompany, listed as TSX Venture Exchange under the trading symbol BABY and\nis quoted on the US OTC Markets QX board under the trading symbol BABYF and\non the Frankfurt Exchange under the symbol 0YL. Else's Executives include\nleaders hailing from leading infant nutrition companies. Many of Else\nadvisory board members had past executive roles in companies such as Mead\nJohnson, Abbott Nutrition, Plum Organics and leading infant nutrition\nSocieties,  and some of them currently serve in different roles in leading\nmedical centers and academic institutes such as Boston Children's Hospital,\nPediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider\nChildren's Medical Center of Israel, Rambam Medical Center and Technion,\nIsrael and University Hospital Brussels, Belgium.\n\n     For more information, visit: elsenutrition.com or @elsenutrition on\nFacebook and Instagram.\n\n Contact Information:\n\nContact:Callie Rapp\nBrilliant PR\ncallierj@brilliantprm.com\n\n     Contact:\nMrs. Hamutal Yitzhak, CEO, Co-Founder &amp; Director\nELSE Nutrition Holdings Inc.\nE: hamutaly@elsenutrition.com\nP: +972(0)3-6445095\n\n     Mr. Sokhie Puar, Lead Director of Else Nutrition\nEmail: sokhiep@elsenutrition.com\nP : 604-603-7787\n\n     US Investor Relations Contact:\n\n     Lytham Partners, LLC\nMr. Ben Shamsian\nNew York | Phoenix\nE: shamsian@lythampartners.com\nP: 646-829-9701\n\n     TSX Venture Exchange\n\n     Neither the TSX Venture Exchange nor its regulation services provider\n(as that term is defined in the policies of the TSX Venture Exchange)\naccepts responsibility for the adequacy or accuracy of this release.\n\n     Caution Regarding Forward-Looking Statements\n\n     This press release contains statements that may constitute\n\"forward-looking statements\" within the meaning of applicable securities\nlegislation. Forward-looking statements are typically identified by words\nsuch as \"will\" or similar expressions. Forward-looking statements in this\npress release include statements with respect to the anticipated dates for\nfiling the Company's financial disclosure documents. Such forward-looking\nstatements reflect current estimates, beliefs and assumptions, which are\nbased on management's perception of current conditions and expected future\ndevelopments, as well as other factors management believes are appropriate\nin the circumstances. No assurance can be given that the foregoing will\nprove to be correct. Forward-looking statements made in this press release\nassume, among others, the expectation that there will be no interruptions\nor supply chain failures as a result of COVID-19 and that the\nmanufacturing, broker and supply logistic agreement with the Company do not\nterminate. Actual results may differ from the estimates, beliefs and\nassumptions expressed or implied in the forward-looking statements. Readers\nare cautioned not to place undue reliance on any forward-looking\nstatements, which reflect management's expectations only as of the date of\nthis press release. The Company disclaims any obligation to update or\nrevise any forward-looking statements, whether as a result of new\ninformation, future events or otherwise, except as required by law.\n\n                         ______________________________________\n       _______________________________________________\n\n     ____________________________________________________________   \n      (c)2021 Market News Publishing Inc.  All rights reserved.    \n Toronto:(416)366-8881   Vancouver:(604)689-1101   Fax:(604)689-1106\n\n     2133900221.MNPRE2133901287-06144420211206</pre>\n</div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright (c) 2021 Thomson Reuters Limited.</p></div>"}